Studies available for: Alzheimers Disease

See a study that interests you? Contact that study's coordinator for more information on how to participate.


Study Information:
A 12-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients with Mild to Moderate Alzheimers Disease
Houston, Tx
Jary M.Lesser, M.D.
Recent studies have shown that the rate of Alzheimers disease among the Hispanic people is higher when compared to Caucasian people. The number of Hispanic subjects taking part in Alzheimer disease clinical research studies continues to be low although the older Hispanic population is growing rapidly. This study will look at more directly the safety and benefit of Aricept in Hispanic subjects with mild to moderate Alzheimers disease. Subjects taking part will receive 5 or 10 mg of Aricept daily for 12 weeks.
HSC-MS-06-0092
Eisai, Inc
Subject Information:
50 and above
Both men and women, 50 years or older. Have mild alzheimers disease. Are not currently being treated with medications specifically for alzheimers disease. Are generally healthy. Have a reliable caregiver. (this list is partial)
Study Coordinator(s) Information:
Saroj (Cindy) Kumar
saroj.kumar@uth.tmc.edu
713-500-2722
Principal Investigator Information:
Jary M Lesser, M.D.